Innovations Driving the Meningococcal Vaccine Market 2026
According to FutureWise analysis, the market for meningococcal vaccine in 2026 is US$ 5.14 billion, and is expected to reach US$ 10.86 billion by 2036 at a CAGR of 7.77%. The growth is fueled by expanding immunization programs, greater awareness of meningococcal disease prevention, and increased vaccine uptake among infants, adolescents, and high-risk groups. Advances in conjugate and...
0 Commenti 0 condivisioni 124 Views 0 Anteprima
Sponsorizzato